Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286892 · ClinicalTrials.gov registry record · NA
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by Louise Reagan.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 2
- Study locations
NCT05286892 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Louise Reagan. The registered enrollment target is 128 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05286892, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Louise Reagan.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study will use a randomized clinical trial design with non-equivalent control group and longitudinal design to evaluate the feasibility, acceptability, and preliminary effects of the Diabetes LIVE JustICE application. The design will incorporate repeated measures at 0, 6, and 12 weeks. Outcome variables will include recruitment assessments, participation, engagement, user experience, and measures proximally related to behavior change - e.g., diabetes knowledge, diabetes-related distress, diabetes self-care, and social support and clinical outcomes -e.g., glycemic control. Focus group interviewing will be conducted to evaluate acceptability among intervention group participants.
Conditions Studied
Interventions
- OTHER Diabetes LIVE JustICE
- OTHER Enhanced Education
Study Locations (2)
Connecticut
- University of Connecticut - Storrs
- University of Connecticut - Storrs Mansfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2023-04-30 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05286892
The ClinicalTrials.gov registry entry for NCT05286892 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (97% lower). The listed sponsor is Louise Reagan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Diabetes LIVE JustICE is the first listed.
NCT05286892 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05286892 about?
NCT05286892 is a clinical study titled "Diabetes Learning in Virtual Environments Just in Time for Community Reentry". The proposed study will use a randomized clinical trial design with non-equivalent control group and longitudinal design to evaluate the feasibility, acceptability, and preliminary effects of the Diabetes LIVE JustICE application. The design will incorporate repeated measures at 0, 6, and 12 weeks. ...
What is the current status of trial NCT05286892?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2023-04-30. Estimated completion is 2026-12-15.
What conditions does trial NCT05286892 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT05286892?
The interventions under investigation include: Diabetes LIVE JustICE (OTHER), Enhanced Education (OTHER).
Who is sponsoring clinical trial NCT05286892?
This trial is sponsored by Louise Reagan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05286892 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Efficacy of Using Mobile Health Applications for Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.